# National Health Investors Inc. (NHI) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Real Estate / Equity Real Estate Investment Trusts (REITs). Price $70.88, market value $3.5 billion.

## Valuation
- **P/E (trailing): 20.5×** (5-yr avg 21.7×, 3-yr avg 20.4×). National Health Investors Inc. trades at 20.5× trailing earnings, close to its own five-year average of 21.7×. The Real Estate median in the September 2026 study was 25.2×. Forward P/E is 21.8×, higher than trailing, so analysts expect earnings to fall.
- **Price / sales: 16.6×**. Each dollar of revenue is priced at 16.6×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 2.2×**. The shares trade at 2.2× book value; book value is a meaningful part of the valuation.
- **Earnings yield: 4.9%**. The inverse of the P/E: 4.9% of the price is earned each year.

## Profitability
- **Net margin: 177.6%**. 177.6% of each dollar of sales reaches the bottom line.
- **Return on equity: 9.3%**. 9.3% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on assets: 6.0%**. Each dollar of assets produces 6.0% of profit.

## Growth
- **Revenue growth (1 yr): 47.1%** (3-yr 30.8%/yr). Revenue grew 47.1% over the last year.
- **EPS growth (1 yr): -3.5%** (3-yr 26.8%/yr, 5-yr -6.1%/yr). Earnings per share fell 3.5%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 0.76**. Debt is 0.76 times equity, moderate leverage.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 5.30%** ($3.68 per share, trailing). National Health Investors Inc. yields 5.30%, an income-level yield.
- **Payout ratio: 119%**. The dividend exceeds earnings (119% payout), which is rarely sustainable outside REITs and one-off years.
- **Consecutive years of increases: 3**. 3 straight years of increases.
- **Dividend growth (5 yr): -3.8%/yr** (1-yr 1.1%). The dividend has not grown over five years.

## Analyst view
- **Analyst consensus: buy** (8 analysts). 8 analysts cover National Health Investors Inc.; the consensus is buy, with an average price target of $81.88 (+16% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -3.8%** (YTD -5.0%, 3-mo 1.8%). The shares are down 3.8% over twelve months including dividends.
- **From 52-week high: -22.4%** (4.3% above the low). Trading 22% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 38**. An RSI of 38 is neutral.
- **Beta (1 yr): -0.30** (volatility 24%). Beta of -0.30 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=NHI · Page: https://foliofundamentals.com/stocks/nhi

Not investment advice.